SHORT-TERM BORROWINGS, LONG-TERM DEBT, AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Debt Disclosure [Abstract] | |
| SHORT-TERM BORROWINGS, LONG-TERM DEBT, AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS | SHORT-TERM BORROWINGS, LONG-TERM DEBT, AVAILABLE CREDIT FACILITIES AND OTHER OBLIGATIONS A summary of DuPont's short-term borrowings, long-term debt and available credit facilities can be found in Note 15 to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025. If applicable, updates have been included below. Commercial Paper At June 30, 2026, the Company had no commercial paper outstanding. At December 31, 2025 the Company had $60 million outstanding of commercial paper. The weighted-average interest rate on the commercial paper was 3.95% at December 31, 2025. Long-Term Debt Long-term debt at June 30, 2026 and December 31, 2025 was $3,125 million and $3,134 million, respectively. At June 30, 2026 and December 31, 2025 the long-term debt balance included an unamortized basis adjustment of $34 million and $35 million related to the dedesignation of the Company's interest rate swap agreements. Additionally, the June 30, 2026 and December 31, 2025 balance included a fair value hedging adjustment of $16 million and $4 million, respectively related to the 2022 Swaps. See Note 17 for additional information. There is no long-term debt due within one year for both periods ending June 30, 2026 and December 31, 2025. Uncommitted Credit Facilities and Outstanding Letters of Credit Unused bank credit lines on uncommitted credit facilities were approximately $477 million at June 30, 2026. These lines are available to support short-term liquidity needs and general corporate purposes, including letters of credit. Outstanding letters of credit were approximately $105 million at June 30, 2026. These letters of credit support commitments made in the ordinary course of business. Revolving Credit Facilities In May 2026, the Company entered into a $750 million 364-day revolving credit facility (the "2026 $750 million Revolving Credit Facility"). Prior to entering the new facility, the Company held a $1 billion 364-day revolving credit facility that expired in May 2026. There were no drawdowns of either facility during the six month period ended June 30, 2026. In May 2026, the Company entered into a $2 billion five-year revolving credit facility (the "2026 Five-Year Revolving Credit Facility"). Prior to entering the new facility, the Company held another $2 billion five-year revolving credit facility that was terminated when the 2026 Five-Year Revolving Credit Facility became effective. There were no drawdowns of either facility during the six month period ended June 30, 2026. Supplier Financing The Company and certain of its designated suppliers, at their sole discretion, participate in a supplier financing program with a financial institution serving as an intermediary. Under this program, the Company agrees to pay the financial institution the stated amount of confirmed invoices from its designated suppliers on the same terms and on the original maturity dates of the confirmed invoices, which have a weighted average payment term of approximately 140 days. The Company does not pay any annual subscription or service fee to the financial institution, nor does the Company reimburse its suppliers for any costs they incur to participate in the program. The Company’s obligations are not impacted by the suppliers’ decision to participate in this program. The Company or the financial institution may terminate the agreement upon at least 30 days notice. The amount of invoices outstanding under the supplier financing programs as of June 30, 2026 and December 31, 2025 was $65 million and $63 million, respectively, and was recorded in " in the interim Condensed Consolidated Balance Sheets.
|